dr. musher discusses the role of regorafenib in advanced hcc
Published 5 years ago • 337 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
1:45
dr. musher on investigational combination therapies in hcc
-
2:02
dr. bruix discusses the application of regorafenib in hcc
-
1:13
dr. musher on immunotherapy versus tkis in hcc
-
7:46
clinical use of regorafenib in mhcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
5:31
practical advice for using regorafenib
-
0:49
dr. daniele on impact of regorafenib in hcc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
8:29
incorporating regorafenib in the hcc treatment landscape
-
4:14
the use of regorafenib in clinical practice
-
9:34
regorafenib in colorectal cancer
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
3:48
clinical experience with regorafenib in hcc
-
1:46
dr. cusnir on the utility of regorafenib in gastric cancer
-
7:01
global use of regorafenib in hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
2:04
dr. bruix on regorafenib in second-line hcc
-
1:01
potential impact of regorafenib in patients with hcc